Quentin Mark Anstee (Quentin M Anstee, Quentin Anstee)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 70

Top Topics

Systematic Review

Juvenile Idiopathic Arthritis

Top Venues

Nature metabolism

Alimentary pharmacology & therapeutics

Hepatology (Baltimore, Md.)

BMJ open gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodriguez-Cuenca, Maria Manuela Tonini, Tamara R Castañeda, Aimo Kannt, Cecília Maria Pereira Rodrigues, Simon Cockell, Olivier Govaere, Ann K Daly, Michael E D Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne-Christine Andréasson, Franklin J Schlerman, Jonathon Marioneaux, Arun Sanyal, Marta B Afonso, Ramy Younes, Yuichiro Amano, Scott L Friedman, Shuang Wang, Dipankar Bhattacharya, Eric Simon, Valérie Paradis, Alastair Burt, Ioanna-Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Pors, Maja Worm Andersen, Michael Feigh, Carla Yunis, Pierre Bedossa, Michelle Stewart, Heather L Cater, Sara E Wells, Jörn Markus Schattenberg, Quentin Mark Anstee, null null, Dina Tiniakos, James W Perfield, Evangelia Petsalaki, Peter Davidsen, Antonio Vidal-Puig
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature metabolism 6 (6) (2024)
Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodriguez-Cuenca, Maria Manuela Tonini, Tamara R Castañeda, Aimo Kannt, Cecília Maria Pereira Rodrigues, Simon Cockell, Olivier Govaere, Ann K Daly, Michael E D Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne-Christine Andréasson, Franklin J Schlerman, Jonathon Marioneaux, Arun Sanyal, Marta B Afonso, Ramy Younes, Yuichiro Amano, Scott L Friedman, Shuang Wang, Dipankar Bhattacharya, Eric Simon, Valérie Paradis, Alastair Burt, Ioanna-Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Pors, Maja Worm Andersen, Michael Feigh, Carla Yunis, Pierre Bedossa, Michelle Stewart, Heather L Cater, Sara E Wells, Jörn Markus Schattenberg, Quentin Mark Anstee, null null, Dina Tiniakos, James W Perfield, Evangelia Petsalaki, Peter Davidsen, Antonio Vidal-Puig
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature metabolism 6 (6) (2024)
Elena Sena, Frank Tacke, Quentin Mark Anstee, Nicholas Di Prospero, Mette Skalshøi-Kjær, Sergio Muñoz-Martínez, Jesús Rivera-Esteban, Alba Jiménez-Masip, Jesús M Bañales, María Martínez-Gómez, Franz Koenig, Joan Genescà, Vlad Ratziu, Juan Manuel Pericàs
Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitis. Communications medicine 4 (1) (2024)
McPherson Stuart, Jessica K Dyson, Laura Jopson, Steven Masson, Preya Patel, Quentin Mark Anstee
How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease? Alimentary pharmacology & therapeutics 60 (2) (2024)
Juan Manuel Pericàs, Quentin Mark Anstee, Salvador Augustin, Ramon A Bataller, Annalisa Berzigotti, Andreea Ciudin, Sven M Francque, Juan G Abraldes, Virginia Hernández-Gea, Mònica Pons, Thomas Reiberger, Denis Moir, Peter Rydqvist, Elmer Schabel, Frank Tacke, Emmanuel A Tsochatzis, Joan Genescà
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis. Nature reviews. Gastroenterology & hepatology (2024)
Elena Sena, Frank Tacke, Quentin Mark Anstee, Nicholas Di Prospero, Mette Skalshøi-Kjær, Sergio Muñoz-Martínez, Jesús Rivera-Esteban, Alba Jiménez-Masip, Jesús M Bañales, María Martínez-Gómez, Franz Koenig, Joan Genescà, Vlad Ratziu, Juan Manuel Pericàs
Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitis. Communications medicine 4 (1) (2024)
Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodriguez-Cuenca, Maria Manuela Tonini, Tamara R Castañeda, Aimo Kannt, Cecília Maria Pereira Rodrigues, Simon Cockell, Olivier Govaere, Ann K Daly, Michael E D Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne-Christine Andréasson, Franklin J Schlerman, Jonathon Marioneaux, Arun Sanyal, Marta B Afonso, Ramy Younes, Yuichiro Amano, Scott L Friedman, Shuang Wang, Dipankar Bhattacharya, Eric Simon, Valérie Paradis, Alastair Burt, Ioanna-Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Pors, Maja Worm Andersen, Michael Feigh, Carla Yunis, Pierre Bedossa, Michelle Stewart, Heather L Cater, Sara E Wells, Jörn Markus Schattenberg, Quentin Mark Anstee, null null, Dina Tiniakos, James W Perfield, Evangelia Petsalaki, Peter Davidsen, Antonio Vidal-Puig
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature metabolism (2024)
Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero Gomez, Jean-Francois Dufour, Mattias Ekstedt, Sven M Francque, Hannele Yki-Jarvinen, Michael Allison, Luca Vittorio Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, Georgios Papatheodoridis, Adriaan G Holleboom, Dina Tiniakos, Clifford Brass, Quentin Mark Anstee, Paolo Missier, null null
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PloS one 19 (2) (2024)
McPherson Stuart, Jessica K Dyson, Laura Jopson, Steven Masson, Preya Patel, Quentin Mark Anstee
Letter: Beyond advanced fibrosis-The critical need for assessing NITs performance in identifying F2-F3 fibrosis. Authors' reply. Alimentary pharmacology & therapeutics (2024)
Elena Sena, Frank Tacke, Quentin Mark Anstee, Nicholas Di Prospero, Mette Skalshøi-Kjær, Sergio Muñoz-Martínez, Jesús Rivera-Esteban, Alba Jiménez-Masip, Jesús M Bañales, María Martínez-Gómez, Franz Koenig, Joan Genescà, Vlad Ratziu, Juan Manuel Pericàs
Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitis. Communications medicine 4 (1) (2024)
Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero Gomez, Jean-Francois Dufour, Mattias Ekstedt, Sven M Francque, Hannele Yki-Jarvinen, Michael Allison, Luca Vittorio Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, Georgios Papatheodoridis, Adriaan G Holleboom, Dina Tiniakos, Clifford Brass, Quentin Mark Anstee, Paolo Missier, null null
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PloS one 19 (2) (2024)
McPherson Stuart, Jessica K Dyson, Laura Jopson, Steven Masson, Preya Patel, Quentin Mark Anstee
How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease? Alimentary pharmacology & therapeutics 60 (2) (2024)
Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero Gomez, Jean-Francois Dufour, Mattias Ekstedt, Sven M Francque, Hannele Yki-Jarvinen, Michael Allison, Luca Vittorio Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, Georgios Papatheodoridis, Adriaan G Holleboom, Dina Tiniakos, Clifford Brass, Quentin Mark Anstee, Paolo Missier, null null
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PloS one 19 (2) (2024)
Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodriguez-Cuenca, Maria Manuela Tonini, Tamara R Castañeda, Aimo Kannt, Cecília Maria Pereira Rodrigues, Simon Cockell, Olivier Govaere, Ann K Daly, Michael E D Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne-Christine Andréasson, Franklin J Schlerman, Jonathon Marioneaux, Arun Sanyal, Marta B Afonso, Ramy Younes, Yuichiro Amano, Scott L Friedman, Shuang Wang, Dipankar Bhattacharya, Eric Simon, Valérie Paradis, Alastair Burt, Ioanna-Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Pors, Maja Worm Andersen, Michael Feigh, Carla Yunis, Pierre Bedossa, Michelle Stewart, Heather L Cater, Sara E Wells, Jörn Markus Schattenberg, Quentin Mark Anstee, null null, Dina Tiniakos, James W Perfield, Evangelia Petsalaki, Peter Davidsen, Antonio Vidal-Puig
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature metabolism 6 (6) (2024)
Juan Manuel Pericàs, Quentin Mark Anstee, Salvador Augustin, Ramon A Bataller, Annalisa Berzigotti, Andreea Ciudin, Sven M Francque, Juan G Abraldes, Virginia Hernández-Gea, Mònica Pons, Thomas Reiberger, Denis Moir, Peter Rydqvist, Elmer Schabel, Frank Tacke, Emmanuel A Tsochatzis, Joan Genescà
A roadmap for clinical trials in MASH-related compensated cirrhosis. Nature reviews. Gastroenterology & hepatology (2024)
McPherson Stuart, Jessica K Dyson, Laura Jopson, Steven Masson, Preya Patel, Quentin Mark Anstee
How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease? Alimentary pharmacology & therapeutics (2024)
Juan Manuel Pericàs, Quentin Mark Anstee, Salvador Augustin, Ramon A Bataller, Annalisa Berzigotti, Andreea Ciudin, Sven M Francque, Juan G Abraldes, Virginia Hernández-Gea, Mònica Pons, Thomas Reiberger, Denis Moir, Peter Rydqvist, Elmer Schabel, Frank Tacke, Emmanuel A Tsochatzis, Joan Genescà
A roadmap for clinical trials in MASH-related compensated cirrhosis. Nature reviews. Gastroenterology & hepatology (2024)
Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodriguez-Cuenca, Maria Manuela Tonini, Tamara R Castañeda, Aimo Kannt, Cecília Maria Pereira Rodrigues, Simon Cockell, Olivier Govaere, Ann K Daly, Michael E D Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne-Christine Andréasson, Franklin J Schlerman, Jonathon Marioneaux, Arun Sanyal, Marta B Afonso, Ramy Younes, Yuichiro Amano, Scott L Friedman, Shuang Wang, Dipankar Bhattacharya, Eric Simon, Valérie Paradis, Alastair Burt, Ioanna-Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Pors, Maja Worm Andersen, Michael Feigh, Carla Yunis, Pierre Bedossa, Michelle Stewart, Heather L Cater, Sara E Wells, Jörn Markus Schattenberg, Quentin Mark Anstee, null null, Dina Tiniakos, James W Perfield, Evangelia Petsalaki, Peter Davidsen, Antonio Vidal-Puig
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature metabolism (2024)
McPherson Stuart, Jessica K Dyson, Laura Jopson, Steven Masson, Preya Patel, Quentin Mark Anstee
Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply. Alimentary pharmacology & therapeutics (2024)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
McPherson Stuart, Helen Jarvis, John McGonigle, Joan Bedlington, Jill Dean, Kate Hallsworth, Elodie Hanon, Trevor Liddle, Ahai Luvai, Dina Mansour, Preya Patel, Laura Renwick, Dawn Teare, Christina Tanney, Quentin Mark Anstee
Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary-secondary care interface. BMJ open gastroenterology 10 (1) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
McPherson Stuart, Helen Jarvis, John McGonigle, Joan Bedlington, Jill Dean, Kate Hallsworth, Elodie Hanon, Trevor Liddle, Ahai Luvai, Dina Mansour, Preya Patel, Laura Renwick, Dawn Teare, Christina Tanney, Quentin Mark Anstee
Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary-secondary care interface. BMJ open gastroenterology 10 (1) (2023)
Olivier Govaere, Megan S R Hasoon, Leigh Alexander, Simon J Cockell, Dina Tiniakos, Mattias Ekstedt, Jörn Markus Schattenberg, Jerome Boursier, Elisabetta Bugianesi, Vlad Ratziu, null null, Ann K Daly, Quentin Mark Anstee
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. Nature metabolism (2023)
Quentin Mark Anstee, Kate Hallsworth, Niall Lynch, Adrien Hauvespre, Eid Mansour, Sam Kozma, Juliana Bottomley, Gary Milligan, James Piercy, Victoria S Higgins
Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey. Pragmatic and observational research 14 (2023)
Stephen A Harrison, Vlad Ratziu, Quentin Mark Anstee, Mazen Noureddin, Arun J Sanyal, Jörn Markus Schattenberg, Pierre Bedossa, Mustafa R Bashir, David Schneider, Rebecca Taub, Meena Bansal, Kris V Kowdley, Zobair M Younossi, Rohit Loomba
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2023)
Quentin Mark Anstee, Kate Hallsworth, Niall Lynch, Adrien Hauvespre, Eid Mansour, Sam Kozma, Juliana Bottomley, Gary Milligan, James Piercy, Victoria S Higgins
Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey. Pragmatic and observational research 14 (2023)
McPherson Stuart, Helen Jarvis, John McGonigle, Joan Bedlington, Jill Dean, Kate Hallsworth, Elodie Hanon, Trevor Liddle, Ahai Luvai, Dina Mansour, Preya Patel, Laura Renwick, Dawn Teare, Christina Tanney, Quentin Mark Anstee
Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary-secondary care interface. BMJ open gastroenterology 10 (1) (2023)
McPherson Stuart, Helen Jarvis, John McGonigle, Joan Bedlington, Jill Dean, Kate Hallsworth, Elodie Hanon, Trevor Liddle, Ahai Luvai, Dina Mansour, Preya Patel, Laura Renwick, Dawn Teare, Christina Tanney, Quentin Mark Anstee
Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary-secondary care interface. BMJ open gastroenterology 10 (1) (2023)
Juan Manuel Pericàs, Nicholas A Di Prospero, Quentin Mark Anstee, Peter Mesenbrinck, Mette S Kjaer, Jesus Manuel Rivera Esteban, Franz Koenig, Elena Sena, Raluca Pais, Ramiro Manzano, Joan Genescà, Frank Tacke, Vlad Ratziu, null null
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials. Alimentary pharmacology & therapeutics (2023)
McPherson Stuart, Helen Jarvis, John McGonigle, Joan Bedlington, Jill Dean, Kate Hallsworth, Elodie Hanon, Trevor Liddle, Ahai Luvai, Dina Mansour, Preya Patel, Laura Renwick, Dawn Teare, Christina Tanney, Quentin Mark Anstee
Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary-secondary care interface. BMJ open gastroenterology 10 (1) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, Enrico Focaccia, Mohammad Rahbari, Adnan Ali, Nisar P Malek, Quentin Mark Anstee, Mathias F Heikenwälder
A researcher's guide to preclinical mouse NASH models. Nature metabolism (2022)
Ibon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, Ruben Gil-Redondo, Itziar Mincholé, Maider Bizkarguenaga, Enara Arretxe, Marta Iruarrizaga-Lejarreta, David Fernández-Ramos, Fernando Lopitz-Otsoa, Rebeca Mayo, Nieves Embade, Elizabeth Newberry, Bettina Mittendorf, Laura Izquierdo-Sánchez, Vaclav Smid, Jorge Arnold, Paula Iruzubieta, Ylenia Pérez Castaño, Marcin Krawczyk, Urko M Marigorta, Martine C Morrison, Robert Kleemann, Antonio Martín-Duce, Liat Hayardeny, Libor Vítek, Radan Brůha, Rocío Aller de la Fuente, Javier Crespo, Manuel Romero, Jesus M Banales, Marco Arrese, Kenneth Cusi, Elisabetta Bugianesi, Samuel Klein, Shelly C Lu, Quentin Mark Anstee, Óscar Millet, Nicholas O Davidson, Cristina Alonso, Jose M Mato
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles. Hepatology (Baltimore, Md.) 76 (4) (2022)
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, Enrico Focaccia, Mohammad Rahbari, Adnan Ali, Nisar P Malek, Quentin Mark Anstee, Mathias F Heikenwälder
A researcher's guide to preclinical mouse NASH models. Nature metabolism 4 (12) (2022)
Rish K Pai, Vipul Jairath, Malcolm Hogan, Guangyong Zou, Oyedele A Adeyi, Quentin Mark Anstee, Bashar A Aqel, Cynthia Behling, Elizabeth J Carey, Andrew D Clouston, Kathleen E Corey, Brian G Feagan, David E Kleiner, Christopher Ma, Stefanie C McFarlane, Mazen Noureddin, Vlad Ratziu, Mark A Valasek, Zobair M Younossi, Stephen A Harrison, Stephen Caldwell
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology (Baltimore, Md.) 76 (4) (2022)
Danielle Brandman, Marie Boyle, McPherson Stuart, Mark L Van Natta, Arun J Sanyal, Kris Kowdley, Brent Neuschwander-Tetri, Naga Chalasani, Manal F Abdelmalek, Norah A Terrault, Art McCullough, Ricki Bettencourt, Cyrielle Caussy, David E Kleiner, Cynthia Behling, James Tonascia, Quentin Mark Anstee, Stephen Caldwell
Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply. Alimentary pharmacology & therapeutics 56 (1) (2022)
Danielle Brandman, Marie Boyle, McPherson Stuart, Mark L Van Natta, Arun J Sanyal, Kris Kowdley, Brent Neuschwander-Tetri, Naga P Chalasani, Manal F Abdelmalek, Norah A Terrault, Art McCullough, Ricki Bettencourt, Cyrielle Caussy, David E Kleiner, Cynthia Behling, James Tonascia, Quentin Mark Anstee, Stephen Caldwell, null null
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD). Alimentary pharmacology & therapeutics 55 (11) (2022)
Daniel Geh, Robyn Watson, Gourab Sen, Jeremy J French, John Hammond, Paul Turner, Tim Hoare, Kirsty Anderson, Michael McNeil, McPherson Stuart, Steven Masson, Jessica Dyson, Mhairi Claire Donnelly, Louise MacDougal, Preya Patel, Mark Hudson, Quentin Mark Anstee, Steven White, Stuart Robinson, Sanjay Pandanaboyana, Lucy Walker, Misti McCain, Yvonne Bury, Shreya Raman, Alastair Burt, Daniel Parkinson, Beate Haugk, Antony Darne, Nick Wadd, Syed Asghar, Lavanya Mariappan, Jane Margetts, Benjamin Stenberg, John Scott, Peter Littler, Derek M Manas, Helen L Reeves
COVID-19 and liver cancer: lost patients and larger tumours. BMJ open gastroenterology 9 (1) (2022)
Vlad Ratziu, Quentin Mark Anstee, Vincent Wai-Sun Wong, Jörn Markus Schattenberg, Elisabetta Bugianesi, Salvador Augustin, Liana Gheorghe, Vittoria Zambon, Nancy S Reau
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT project. Hepatology (Baltimore, Md.) 76 (6) (2022)
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, Enrico Focaccia, Mohammad Rahbari, Adnan Ali, Nisar P Malek, Quentin Mark Anstee, Mathias F Heikenwälder
A researcher's guide to preclinical mouse NASH models. Nature metabolism 4 (12) (2022)
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, Enrico Focaccia, Mohammad Rahbari, Adnan Ali, Nisar P Malek, Quentin Mark Anstee, Mathias F Heikenwälder
A researcher's guide to preclinical mouse NASH models. Nature metabolism 4 (12) (2022)
Christian A Hudert, Leon A Adams, Anna Alisi, Quentin Mark Anstee, Annalisa Crudele, Laura G Draijer, null null, Samuel Furse, Jan G Hengstler, Benjamin Jenkins, Kylie Karnebeek, Deirdre A Kelly, Bart G Koot, Albert Koulman, David Meierhofer, Phillip E Melton, Trevor A Mori, Stuart G Snowden, Indra van Mourik, Anita Vreugdenhil, Susanna Wiegand, Jake Peter Mann
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. Hepatology communications 6 (8) (2022)
Yasaman Vali, Roel Eijk, Timothy Hicks, William S Jones, Jana Suklan, Adriaan G Holleboom, Vlad Ratziu, Miranda W Langendam, Quentin Mark Anstee, Patrick M M Bossuyt, null null
Clinicians' Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study. Journal of clinical medicine 11 (10) (2022)
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, Enrico Focaccia, Mohammad Rahbari, Adnan Ali, Nisar P Malek, Quentin Mark Anstee, Mathias F Heikenwälder
A researcher's guide to preclinical mouse NASH models. Nature metabolism 4 (12) (2022)
Jean-François Dufour, Quentin Mark Anstee, Elisabetta Bugianesi, Stephen Harrison, Stephen Caldwell, Valerie Paradis, Herbert Tilg, Vincent Wai-Sun Wong, Shira Zelber-Sagi
Current therapies and new developments in NASH. Gut (2022)
Jeffrey Victor Lazarus, Quentin Mark Anstee, Hannes Hagström, Kenneth Cusi, Helena Cortez-Pinto, Henry E Mark, Michael Roden, Emmanuel A Tsochatzis, Vincent Wai-Sun Wong, Zobair M Younossi, Shira Zelber-Sagi, Manuel Romero, Jörn Markus Schattenberg
Defining comprehensive models of care for NAFLD. Nature reviews. Gastroenterology & hepatology 18 (10) (2021)
Olivier Govaere, Simon J Cockell, Dina Tiniakos, Rachel Queen, Ramy Younes, Michele Vacca, Leigh Alexander, Federico Ravaioli, Jeremy Palmer, Salvatore Petta, Jerome Boursier, Chiara Rosso, Katherine Johnson, Kristy Wonders, Christopher P Day, Mattias Ekstedt, Matej Oresic, Rebecca Darlay, Heather J Cordell, Fabio Marra, Antonio Vidal-Puig, Pierre Bedossa, Jörn Markus Schattenberg, Karine Clement, Michael E D Allison, Elisabetta Bugianesi, Vlad Ratziu, Ann K Daly, Quentin Mark Anstee
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Science translational medicine 12 (572) (2021)
Yasaman Vali, Jenny A Lee, Jérôme Boursier, Rene Spijker, Joanne Verheij, M Julia Brosnan, Quentin Mark Anstee, Patrick M Bossuyt, Mohammad Hadi Zafarmand, null On Behalf Of The Litmus Systematic Review Team
FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis. Journal of clinical medicine 10 (11) (2021)
Lai Wei, Pik-Eu Jason Chang, Quentin Mark Anstee
Reply. Hepatology (Baltimore, Md.) 72 (2) (2021)
Jeffrey Victor Lazarus, Henry E Mark, Quentin Mark Anstee, Juan Pablo Arab, Rachel L Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M Ashworth Dirac, Sven M Francque, Jacob George, Hannes Hagström, Terry T K Huang, Mona H Ismail, Achim Kautz, Shiv Kumar Sarin, Stephen Caldwell, Veronica Miller, Philip N Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary Rinella, Diana Romero, Manuel Romero, Jörn Markus Schattenberg, Emmanuel A Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M Younossi, Shira Zelber-Sagi, null null
Advancing the global public health agenda for NAFLD: a consensus statement. Nature reviews. Gastroenterology & hepatology (2021)
Sophie C Cazanave, Andrew D Warren, Maciej Pacula, Fayçal Touti, Anna Zagorska, Nil Gural, Eric K Huang, Sarah Sherman, Mehar Cheema, Sabrina Ibarra, Jamie Bates, Andrew N Billin, John T Liles, Grant R Budas, David G Breckenridge, Dina Tiniakos, Vlad Ratziu, Ann K Daly, Olivier Govaere, Quentin Mark Anstee, Louis Gelrud, Jay Luther, Raymond T Chung, Kathleen E Corey, Wendy Winckler, Sangeeta N Bhatia, Gabriel A Kwong
Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors. Science translational medicine 13 (616) (2021)
Anne Linde Mak, Jenny Lee, Anne-Marieke Van Dijk, Yasaman Vali, Guruprasad P Aithal, Jörn Markus Schattenberg, Quentin Mark Anstee, M Julia Brosnan, Mohammad Hadi Zafarmand, Dewkoemar Ramsoekh, Stephen A Harrison, Max Nieuwdorp, Patrick M Bossuyt, Adriaan G Holleboom
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 9 (12) (2021)
Kate Hallsworth, McPherson Stuart, Quentin Mark Anstee, Darren Flynn, Laura Haigh, Leah Avery
Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping. Journal of medical Internet research 23 (1) (2021)
Anne-Marieke Van Dijk, Yasaman Vali, Anne Linde Mak, Jenny Lee, Maarten E Tushuizen, Mohammad Hadi Zafarmand, Quentin Mark Anstee, M Julia Brosnan, Max Nieuwdorp, Patrick M Bossuyt, Adriaan G Holleboom
Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease. Journal of clinical medicine 10 (13) (2021)
Ramy Youne, Olivier Govaere, Salvatore Petta, Luca Miele, Dina Tiniakos, Alastair Burt, Ezio David, Fabio Maria Vecchio, Marco Maggioni, Daniela Cabibi, Duncan McLeod, Maria Jesus Pareja, Anna Ludovica Fracanzani, Rocio Aller, Chiara Rosso, Javier Ampuero, Rocío Gallego-Durán, Angelo Armandi, Gian Paolo Caviglia, Marco Y W Zaki, Antonio Liguori, Paolo Francione, Grazia Pennisi, Antonio Grieco, Giovanni Birolo, Piero Fariselli, Mohammed Eslam, Luca Vittorio Valenti, Jacob George, Manuel Romero-Gómez, Quentin Mark Anstee, Elisabetta Bugianesi
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? Gut (2021)
Amaro Taylor-Weiner, Harsha Pokkalla, Ling Han, Catherine Jia, Ryan Huss, Chuhan Chung, Hunter Elliott, Benjamin Glass, Kishalve Pethia, Oscar Carrasco-Zevallos, Chinmay Shukla, Urmila Khettry, Robert Najarian, Ross Taliano, G Mani Subramanian, Robert P Myers, Ilan Wapinski, Aditya Khosla, Murray Resnick, Michael C Montalto, Quentin Mark Anstee, Vincent Wai-Sun Wong, Michael Trauner, Eric J Lawitz, Stephen A Harrison, Takeshi Okanoue, Manuel Romero, Zachary Goodman, Rohit Loomba, Andrew H Beck, Zobair M Younossi
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH. Hepatology (Baltimore, Md.) 74 (1) (2021)
Kazuhiro Kozumi, Takahiro Kodama, Hiroki Murai, Sadatsugu Sakane, Olivier Govaere, Simon Cockell, Daisuke Motooka, Naruyasu Kakita, Yukinori Yamada, Yasuteru Kondo, Yuki Tahata, Ryoko Yamada, Hayato Hikita, Ryotaro Sakamori, Yoshihiro Kamada, Ann K Daly, Quentin Mark Anstee, Tomohide Tatsumi, Eiichi Morii, Tetsuo Takehara
Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis. Hepatology (Baltimore, Md.) 74 (5) (2021)
Mojgan Masoodi, Francesco Rubino, Tuulia Hyötyläinen, Enara Arretxe, Cristina Alonso, Melania Gaggini, Julia Brosnan, Quentin Mark Anstee, Oscar Millet, Pablo Ortiz, Jose M Mato, Jean-François Dufour, Matej Orešič
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nature reviews. Gastroenterology & hepatology 18 (12) (2021)
Jenny A Lee, Yasaman Vali, Jerome Boursier, Rene Spijker, Quentin Mark Anstee, Patrick M Bossuyt, Mohammad H Zafarmand
Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review. Liver international : official journal of the International Association for the Study of the Liver 41 (2) (2021)
Nardeen Eldafashi, Rebecca Darlay, Ruchi Shukla, Misti Vanette McCain, Robyn Watson, Yang Lin Liu, Nikki McStraw, Moustafa Fathy, Michael Atef Fawzy, Marco Y W Zaki, Ann K Daly, João P Maurício, Alastair D Burt, Beate Haugk, Heather J Cordell, Cristiana Bianco, Jean-François Dufour, Luca Vittorio Valenti, Quentin Mark Anstee, Helen L Reeves
A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC? Cancers 13 (6) (2021)
Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Manal F Abdelmalek, Dora Ding, Ling Han, Catherine Jia, Ryan S Huss, Chuhan Chung, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gomez, Andrew J Muir, Nezam H Afdhal, Jaime Bosch, Zachary Goodman, Stephen A Harrison, Zobair M Younossi, Robert P Myers
Cirrhosis Regression is Associated with Improved Clinical Outcomes in Patients with Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.) (2021)
Jenny A Lee, Yasaman Vali, Jérôme Boursier, Kevin Duffin, Joanne Verheij, M Julia Brosnan, Koos Zwinderman, Quentin Mark Anstee, Patrick M Bossuyt, Mohammad Hadi Zafarmand
Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis. PloS one 15 (9) (2020)
Federico Ravaioli, Quentin Mark Anstee
Editorial: collagen proportionate area as a prognostic indicator in NAFLD. Alimentary pharmacology & therapeutics 49 (11) (2020)
Feng Liu, George Boon-Bee Goh, Dina Tiniakos, Aileen Wee, Wei-Qiang Leow, Jing-Min Zhao, Hui-Ying Rao, Xiao-Xiao Wang, Qin Wang, Wei-Keat Wan, Kiat-Hon Lim, Manuel Romero-Gomez, Salvatore Petta, Elisabetta Bugianesi, Chee-Kiat Tan, Stephen A Harrison, Quentin Mark Anstee, Pik-Eu Jason Chang, Lai Wei
qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.) 71 (6) (2020)
Zoe Hall, Davide Chiarugi, Evelina Charidemou, Jack Leslie, Emma Scott, Luca Pellegrinet, Michael Allison, Gabriele Mocciaro, Quentin Mark Anstee, Gerard I Evan, Matthew Hoare, Antonio Vidal-Puig, Fiona Oakley, Michele Vacca, Julian Leether Griffin
Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma. Hepatology (Baltimore, Md.) 73 (3) (2020)
Zobair M Younossi, Vincent Wai-Sun Wong, Quentin Mark Anstee, Manuel Romero, Michael H Trauner, Stephen A Harrison, Eric J Lawitz, Takeshi Okanoue, Marianne Camargo, Kathryn Kersey, Robert P Myers, Zachary Goodman, Maria Stepanova
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes. Hepatology communications 4 (11) (2020)
Michele Vacca, Jack Leslie, Samuel Virtue, Brian Y H Lam, Olivier Govaere, Dina Tiniakos, Sophie Snow, Susan Davies, Kasparas Petkevicius, Zhen Tong, Vivian Peirce, Mette Juul Nielsen, Zsuzsanna Ament, Wei Li, Tomasz Kostrzewski, Diana Julie Leeming, Vlad Ratziu, Michael E D Allison, Quentin Mark Anstee, Julian L Griffin, Fiona Oakley, Antonio Vidal-Puig
Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis. Nature metabolism 2 (6) (2020)
Marie Boyle, Quentin Mark Anstee
Editorial: hepatocellular carcinoma in non-cirrhotic NASH-a troubling reality. Alimentary pharmacology & therapeutics 48 (9) (2019)
Mikolaj Ogrodnik, Satomi Miwa, Tamar Tchkonia, Dina Tiniakos, Caroline L Wilson, Albert Lahat, Christoper P Day, Alastair Burt, Allyson K Palmer, Quentin Mark Anstee, Sushma Nagaraja Grellscheid, Jan H J Hoeijmakers, Sander Barnhoorn, Derek A Mann, Thomas G Bird, Wilbert P Vermeij, James L Kirkland, João F Passos, Thomas von Zglinicki, Diana Jurk
Cellular senescence drives age-dependent hepatic steatosis. Nature communications 8 (2017)